CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3

Cancer Cell

Volumn 19, Issue 4, 2011, Pages 541-555

  Chen, Jingqi ^a,b   Yao, Yandan ^a   Gong, Chang ^a   Yu, Fengyan ^a   Su, Shicheng ^a   Chen, Jianing ^a   Liu, Bodu ^a   Deng, Hui ^c   Wang, Fengsong ^c   Lin, Ling ^a   Yao, Herui ^a   Su, Fengxi ^a   Anderson, Karen S ^d   Liu, Qiang ^a,d   Ewen, Mark E ^d   Yao, Xuebiao ^c   Song, Erwei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCL18 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; INTEGRIN; MEMBRANE RECEPTOR; PROTEIN PITPNM3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; BREAST METASTASIS; CANCER INVASION; CELL ADHESION; CONTROLLED STUDY; CORRELATION COEFFICIENT; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 79953747613     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2011.02.006     Document Type: Article

References (36)

1. Adema G.J., Hartgers F., Verstraten R., de Vries E., Marland G., Menon S., Foster J., Xu Y., Nooyen P., McClanahan T., et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997, 387:713-717.
2. Amarilio R., Ramachandran S., Sabanay H., Lev S. Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J. Biol. Chem. 2005, 280:5934-5944.
3. Chang C.Y., Lee Y.H., Leu S.J., Wang C.Y., Wei C.P., Hung K.S., Pai M.H., Tsai M.D., Wu C.H. CC-chemokine ligand 18/pulmonary activation-regulated chemokine expression in the CNS with special reference to traumatic brain injuries and neoplastic disorders. Neuroscience 2010, 165:1233-1243.
4. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266.
5. Coussens L.M., Tinkle C.L., Hanahan D., Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103:481-490.
6. DeNardo D.G., Barreto J.B., Andreu P., Vasquez L., Tawfik D., Kolhatkar N., Coussens L.M. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009, 16:91-102.
7. Dirkx A.E., Oude Egbrink M.G., Wagstaff J., Griffioen A.W. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J. Leukoc. Biol. 2006, 80:1183-1196.
8. Duluc D., Corvaisier M., Blanchard S., Catala L., Descamps P., Gamelin E., Ponsoda S., Delneste Y., Hebbar M., Jeannin P. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int. J. Cancer 2009, 125:367-373.
9. Gocheva V., Wang H.W., Gadea B.B., Shree T., Hunter K.E., Garfall A.L., Berman T., Joyce J.A. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 2010, 24:241-255.
10. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
11. Goswami S., Sahai E., Wyckoff J.B., Cammer M., Cox D., Pixley F.J., Stanley E.R., Segall J.E., Condeelis J.S. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 2005, 65:5278-5283.
12. Jin T., Xu X., Hereld D. Chemotaxis, chemokine receptors and human disease. Cytokine 2008, 44:1-8.
13. Kodelja V., Muller C., Politz O., Hakij N., Orfanos C.E., Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J. Immunol. 1998, 160:1411-1418.
14. Lazennec G., Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med. 2010, 16:133-144.
15. Leek R.D., Talks K.L., Pezzella F., Turley H., Campo L., Brown N.S., Bicknell R., Taylor M., Gatter K.C., Harris A.L. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res. 2002, 62:1326-1329.
16. Leung S.Y., Yuen S.T., Chu K.M., Mathy J.A., Li R., Chan A.S., Law S., Wong J., Chen X., So S. Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology 2004, 127:457-469.
17. Lev S. The role of the Nir/rdgB protein family in membrane trafficking and cytoskeleton remodeling. Exp. Cell Res. 2004, 297:1-10.
18. Lev S., Hernandez J., Martinez R., Chen A., Plowman G., Schlessinger J. Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein. Mol. Cell. Biol. 1999, 19:2278-2288.
19. Lichtenberger B.M., Tan P.K., Niederleithner H., Ferrara N., Petzelbauer P., Sibilia M. Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell 2010, 140:268-279.
20. Ling K., Wang P., Zhao J., Wu Y.L., Cheng Z.J., Wu G.X., Hu W., Ma L., Pei G. Five-transmembrane domains appear sufficient for a G protein-coupled receptor: functional five-transmembrane domain chemokine receptors. Proc. Natl. Acad. Sci. USA 1999, 96:7922-7927.
21. Mancino A., Lawrence T. Nuclear factor-kappaB and tumor-associated macrophages. Clin. Cancer Res. 2010, 16:784-789.
22. Mantovani A., Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 2010, 22:231-237.
23. Mantovani A., Marchesi F., Porta C., Sica A., Allavena P. Inflammation and cancer: breast cancer as a prototype. Breast 2007, 16(Suppl 2):S27-S33.
24. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 2009, 27:451-483.
25. Murdoch C., Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000, 95:3032-3043.
26. Pittet M.J. Behavior of immune players in the tumor microenvironment. Curr. Opin. Oncol. 2009, 21:53-59.
27. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4:71-78.
28. Robinson B.D., Sica G.L., Liu Y.F., Rohan T.E., Gertler F.B., Condeelis J.S., Jones J.G. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin. Cancer Res. 2009, 15:2433-2441.
29. Schutyser E., Richmond A., Van Damme J. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J. Leukoc. Biol. 2005, 78:14-26.
30. Schutyser E., Struyf S., Proost P., Opdenakker G., Laureys G., Verhasselt B., Peperstraete L., Van de Putte I., Saccani A., Allavena P., et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J. Biol. Chem. 2002, 277:24584-24593.
31. Simpson-Haidaris P.J., Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann. N Y Acad. Sci. 2001, 936:406-425.
32. Solinas G., Germano G., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 2009, 86:1065-1073.
33. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
34. Vandercappellen J., Van Damme J., Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 2008, 267:226-244.
35. Wong S.K. G protein selectivity is regulated by multiple intracellular regions of GPCRs. Neurosignals 2003, 12:1-12.
36. Zohny S.F., Fayed S.T. Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer. Med. Oncol. 2010, 27:1246-1253.